What “approved” means on a Strand record

Every Strand peptide record carries a status tag: approved, investigational, or research. The tag names the object. It does not grade the trials. A High evidence grade and an approved status can sit on the same record. They answer different questions.

Approved means a regulator has approved a specific product for a specific use. The labelled use is the measured use. It is not a property of a sequence, and it is not inherited by a research compound that shares a name.

Approved is a product and a use

Tesamorelin is the clean case. The catalog marks it approved and High. The FDA-approved product is Egrifta. The labelled use is reduction of excess abdominal fat in HIV-associated lipodystrophy. Falutz et al. measured that use in people with HIV. The prescribing information is about that use. None of that makes tesamorelin a general fat-loss drug, and none of it makes another chain sold as a GHRH analog an approved medicine.

Semaglutide is approved for labelled uses that large trials actually measured. STEP 1 measured weight change in adults with overweight or obesity. SELECT later measured cardiovascular outcomes in a related population without diabetes. The Wegovy prescribing information is a separate object from those papers. The status is approved because a product exists for those labelled uses. The grade is High because the human record for those uses is large. The two facts travel together on this record. They are still two facts.

Investigational is a trial product, not an approved medicine

Retatrutide is investigational in the catalog. Jastreboff et al. reported a phase 2 obesity trial in 2023. That is human data. It is not an approval. Status stays investigational until a regulator approves a specific product for a specific use. A phase 2 result can support a Moderate grade. It cannot make the status approved.

Research names a compound without a labelled product

BPC-157 is research and preclinical. A 2019 review of musculoskeletal work is a review of animals. Published quality human randomized trials are absent. The sequence can be discussed. It does not have a US labelled product. Calling it approved because it is sold, nominated, or widely mentioned would collapse the tag.

The tag does not move with the name

A research compound with a similar name does not inherit approval. Approval attaches to a finished product, a manufacturer, and a labelled use. Tesamorelin’s approval does not cover a research GHRH analog. Semaglutide’s approval does not cover a similarly named research compound. Retatrutide’s trial product is not the listing on a research-chemical page.

Status also does not borrow from grade. A High grade on an approved product is about the measured labelled use. A Moderate grade on an investigational product is about unfinished human data. A Preclinical grade on a research compound is about the absence of an adequate human record. Mixing those sentences is how “approved” starts to mean “popular.”

How to read the tag

• Read status as the object: approved medicine, investigational product, or research compound.
• Read the labelled use, if there is one, as the use the trials measured.
• Read the evidence grade next. It is not a second status tag.
• Do not move an approved tag onto a research compound because the names look alike.

The tag will not tell you what to take. It will tell you what kind of object the record is describing.